-
1
-
-
84892805731
-
Cancer statistics
-
R. Siegel, J.M. Ma, Z.H. Zou and A. Jemal, Cancer statistics, Ca-a Cancer Journal for Clinicians 64 (2014), 9-29.
-
(2014)
Ca-A Cancer Journal for Clinicians
, vol.64
, pp. 9-29
-
-
Siegel, R.1
Ma, J.M.2
Zou, Z.H.3
Jemal, A.4
-
2
-
-
33750315764
-
Survival of patients with stage i lung cancer detected on CT screening
-
International Early Lung Cancer Action Program Investigators
-
International Early Lung Cancer Action Program Investigators, C.I. Henschke, D.F. Yankelevitz, D.M. Libby, M.W. Pasmantier, J.P. Smith and O.S. Miettinen, Survival of patients with stage I lung cancer detected on CT screening, New England Journal of Medicine 355 (2006), 1763-1771.
-
(2006)
New England Journal of Medicine
, vol.355
, pp. 1763-1771
-
-
Henschke, C.I.1
Yankelevitz, D.F.2
Libby, D.M.3
Pasmantier, M.W.4
Smith, J.P.5
Miettinen, O.S.6
-
3
-
-
68149182606
-
Functional targeting of the MUC1 oncogene in human cancers
-
D.W. Kufe, Functional targeting of the MUC1 oncogene in human cancers, Cancer Biology & Therapy 8 (2009), 1197-1203.
-
(2009)
Cancer Biology & Therapy
, vol.8
, pp. 1197-1203
-
-
Kufe, D.W.1
-
5
-
-
82755195700
-
MUC1 protein expression in tumor cells regulates transcription of proinflammatory cytokines by forming a complex with nuclear factor-kappaB p65 and binding to cytokine promoters: Importance of extracellular domain
-
S. Cascio, L. Zhang and O.J. Finn, MUC1 protein expression in tumor cells regulates transcription of proinflammatory cytokines by forming a complex with nuclear factor-kappaB p65 and binding to cytokine promoters: importance of extracellular domain, Journal of Biological Chemistry 286 (2011), 42248-42256.
-
(2011)
Journal of Biological Chemistry
, vol.286
, pp. 42248-42256
-
-
Cascio, S.1
Zhang, L.2
Finn, O.J.3
-
6
-
-
66149151809
-
MUC1-induced transcriptional programs associated with tumorigenesis predict outcome in breast and lung cancer
-
N.N. Khodarev, S.P. Pitroda, M.A. Beckett, D.M. Mac-Dermed, L. Huang, D.W. Kufe and R.R. Weichselbaum, MUC1-induced transcriptional programs associated with tumorigenesis predict outcome in breast and lung cancer, Cancer Research 69 (2009), 2833-2837.
-
(2009)
Cancer Research
, vol.69
, pp. 2833-2837
-
-
Khodarev, N.N.1
Pitroda, S.P.2
Beckett, M.A.3
Mac-Dermed, D.M.4
Huang, L.5
Kufe, D.W.6
Weichselbaum, R.R.7
-
7
-
-
9144251970
-
Gene expression profiling identifies clinically relevant subtypes of prostate cancer
-
J. Lapointe, C. Li, J.P. Higgins, M. van de Rijn, E. Bair, K. Montgomery, M. Ferrari, L. Egevad, W. Rayford, U. Bergerheim, P. Ekman, A.M. De Marzo, R. Tibshirani, D. Botstein, P.O. Brown, J.D. Brooks and J.R. Pollack, Gene expression profiling identifies clinically relevant subtypes of prostate cancer, Proc Natl Acad Sci USA 101 (2004), 811-816.
-
(2004)
Proc Natl Acad Sci USA
, vol.101
, pp. 811-816
-
-
Lapointe, J.1
Li, C.2
Higgins, J.P.3
Van De Rijin, M.4
Bair, E.5
Montgomery, K.6
Ferrari, M.7
Egevad, L.8
Rayford, W.9
Bergerheim, U.10
Ekman, P.11
De Marzo, A.M.12
Tibshirani, R.13
Botstein, D.14
Brown, P.O.15
Brooks, J.D.16
Pollack, J.R.17
-
8
-
-
2542632632
-
Genome-wide profiling of papillary thyroid cancer identifies MUC1 as an independent prognostic marker
-
V.B. Wreesmann, E.M. Sieczka, N.D. Socci, M. Hezel, T.J. Belbin, G. Childs, S.G. Patel, K.N. Patel, G. Tallini, M. Prystowsky, A.R. Shaha, D. Kraus, J.P. Shah, P.H. Rao, R. Ghossein and B. Singh, Genome-wide profiling of papillary thyroid cancer identifies MUC1 as an independent prognostic marker, Cancer Research 64 (2004), 3780-3789.
-
(2004)
Cancer Research
, vol.64
, pp. 3780-3789
-
-
Wreesmann, V.B.1
Sieczka, E.M.2
Socci, N.D.3
Hezel, M.4
Belbin, T.J.5
Childs, G.6
Patel, S.G.7
Patel, K.N.8
Tallini, G.9
Prystowsky, M.10
Shaha, A.R.11
Kraus, D.12
Shah, J.P.13
Rao, P.H.14
Ghossein, R.15
Singh, B.16
-
9
-
-
65249127544
-
MUC1-induced alterations in a lipid metabolic gene network predict response of human breast cancers to tamoxifen treatment
-
S.P. Pitroda, N.N. Khodarev, M.A. Beckett, D.W. Kufe and R.R. Weichselbaum, MUC1-induced alterations in a lipid metabolic gene network predict response of human breast cancers to tamoxifen treatment, Proc Natl Acad Sci USA 106 (2009), 5837-5841.
-
(2009)
Proc Natl Acad Sci USA
, vol.106
, pp. 5837-5841
-
-
Pitroda, S.P.1
Khodarev, N.N.2
Beckett, M.A.3
Kufe, D.W.4
Weichselbaum, R.R.5
-
10
-
-
84863692393
-
A novel survival-based tissue microarray of pancreatic cancer validates MUC1 and mesothelin as biomarkers
-
J.M. Winter, L.H. Tang, D.S. Klimstra, M.F. Brennan, J.R. Brody, F.G. Rocha, X. Jia, L.X. Qin, M.I. D'Angelica, R.P. De Matteo, Y. Fong, W.R. Jarnagin, E.M. O'Reilly and P.J. Allen, A novel survival-based tissue microarray of pancreatic cancer validates MUC1 and mesothelin as biomarkers, PLoS One 7 (2012), e40157.
-
(2012)
PLoS One
, vol.7
, pp. e40157
-
-
Winter, J.M.1
Tang, L.H.2
Klimstra, D.S.3
Brennan, M.F.4
Brody, J.R.5
Rocha, F.G.6
Jia, X.7
Qin, L.X.8
D'Angelica, M.I.9
De Matteo, R.P.10
Fong, Y.11
Jarnagin, W.R.12
O'Reilly, E.M.13
Allen, P.J.14
-
11
-
-
2042497140
-
Expression of MUC1, MUC2, MUC5AC, and MUC6 in atypical adenomatous hyperplasia, bronchioloalveolar carcinoma, adenocarcinoma with mixed subtypes, and mucinous bronchioloalveolar carcinoma of the lung
-
H. Awaya, Y. Takeshima, M. Yamasaki and K. Inai, Expression of MUC1, MUC2, MUC5AC, and MUC6 in atypical adenomatous hyperplasia, bronchioloalveolar carcinoma, adenocarcinoma with mixed subtypes, and mucinous bronchioloalveolar carcinoma of the lung, American Journal of Clinical Pathology 121 (2004), 644-653.
-
(2004)
American Journal of Clinical Pathology
, vol.121
, pp. 644-653
-
-
Awaya, H.1
Takeshima, Y.2
Yamasaki, M.3
Inai, K.4
-
12
-
-
84859864764
-
MUC1 expression in pulmonary metastatic tumors: A comparison of primary lung cancer
-
K. Kaira, T. Okumura, K. Nakagawa, Y. Ohde, T. Takahashi, H. Murakami, T. Naito, M. Endo, H. Kondo, T. Nakajima and N. Yamamoto, MUC1 expression in pulmonary metastatic tumors: A comparison of primary lung cancer, Pathology & Oncology Research 18 (2012), 439-447.
-
(2012)
Pathology & Oncology Research
, vol.18
, pp. 439-447
-
-
Kaira, K.1
Okumura, T.2
Nakagawa, K.3
Ohde, Y.4
Takahashi, T.5
Murakami, H.6
Naito, T.7
Endo, M.8
Kondo, H.9
Nakajima, T.10
Yamamoto, N.11
-
13
-
-
84894026684
-
CEA, AFP, CA125, CA153 and CA199 in malignant pleural effusions predict the cause
-
X.F. Wang, Y.H. Wu, M.S. Wang and Y.S. Wang, CEA, AFP, CA125, CA153 and CA199 in malignant pleural effusions predict the cause, Asian Pacific Journal of Cancer Prevention 15 (2014), 363-368.
-
(2014)
Asian Pacific Journal of Cancer Prevention
, vol.15
, pp. 363-368
-
-
Wang, X.F.1
Wu, Y.H.2
Wang, M.S.3
Wang, Y.S.4
-
14
-
-
0026078140
-
A comparative analysis of three different techniques for the detection of breast cancer cells in bone marrow
-
A. Molino, M. Colombatti, F. Bonetti, M. Zardini, F. Pasini, A. Perini, G. Pelosi, G. Tridente, D. Veneri and G.L. Cetto, A comparative analysis of three different techniques for the detection of breast cancer cells in bone marrow, Cancer 67 (1991), 1033-1036.
-
(1991)
Cancer
, vol.67
, pp. 1033-1036
-
-
Molino, A.1
Colombatti, M.2
Bonetti, F.3
Zardini, M.4
Pasini, F.5
Perini, A.6
Pelosi, G.7
Tridente, G.8
Veneri, D.9
Cetto, G.L.10
-
15
-
-
0027374446
-
Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques
-
A.A. Ross, B.W. Cooper, H.M. Lazarus, W. Mackay, T.J. Moss, N. Ciobanu, M.S. Tallman, M.J. Kennedy, N.E. Davidson and D. Sweet, Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques, Blood 82 (1993), 2605-2610.
-
(1993)
Blood
, vol.82
, pp. 2605-2610
-
-
Ross, A.A.1
Cooper, B.W.2
Lazarus, H.M.3
Mackay, W.4
Moss, T.J.5
Ciobanu, N.6
Tallman, M.S.7
Kennedy, M.J.8
Davidson, N.E.9
Sweet, D.10
-
16
-
-
38849205404
-
DNA aptamers against the MUC1 tumourmarker: Design of aptamer-antibody sandwich ELISA for the early diagnosis of epithelial tumours
-
C.S. Ferreira, K. Papamichael, G. Guilbault, T. Schwarzacher, J. Gariepy and S. Missailidis, DNA aptamers against the MUC1 tumourmarker: Design of aptamer-antibody sandwich ELISA for the early diagnosis of epithelial tumours, Analytical and Bioanalytical Chemistry 390 (2008), 1039-1050.
-
(2008)
Analytical and Bioanalytical Chemistry
, vol.390
, pp. 1039-1050
-
-
Ferreira, C.S.1
Papamichael, K.2
Guilbault, G.3
Schwarzacher, T.4
Gariepy, J.5
Missailidis, S.6
-
17
-
-
33845414474
-
Intensive post-operative follow-up of breast cancer patients with tumour markers: CEA, TPA or CA15.3 vs MCA and MCA-CA15.3 vs CEA-TPA-CA15.3 panel in the early detection of distant metastases
-
A. Nicolini, G. Tartarelli, A. Carpi, M.R. Metelli, P. Ferrari, L. Anselmi, M. Conte, P. Berti and P. Miccoli, Intensive post-operative follow-up of breast cancer patients with tumour markers: CEA, TPA or CA15.3 vs MCA and MCA-CA15.3 vs CEA-TPA-CA15.3 panel in the early detection of distant metastases, BMC Cancer 6 (2006), 269.
-
(2006)
BMC Cancer
, vol.6
, pp. 269
-
-
Nicolini, A.1
Tartarelli, G.2
Carpi, A.3
Metelli, M.R.4
Ferrari, P.5
Anselmi, L.6
Conte, M.7
Berti, P.8
Miccoli, P.9
-
18
-
-
33644544070
-
Serum tumor markers in breast cancer: Are they of clinical value?
-
M.J. Duffy, Serum tumor markers in breast cancer: Are they of clinical value? Clinical Chemistry 52 (2006), 345-351.
-
(2006)
Clinical Chemistry
, vol.52
, pp. 345-351
-
-
Duffy, M.J.1
-
19
-
-
77951791725
-
MUC1-associated proliferation signature predicts outcomes in lung adenocarcinoma patients
-
D.M. MacDermed, N.N. Khodarev, S.P. Pitroda, D.C. Edwards, C.A. Pelizzari, L. Huang, D.W. Kufe and R.R. Weichselbaum, MUC1-associated proliferation signature predicts outcomes in lung adenocarcinoma patients, BMCMedical Genomics 3 (2010), 16.
-
(2010)
BMCMedical Genomics
, vol.3
, pp. 16
-
-
MacDermed, D.M.1
Khodarev, N.N.2
Pitroda, S.P.3
Edwards, D.C.4
Pelizzari, C.A.5
Huang, L.6
Kufe, D.W.7
Weichselbaum, R.R.8
-
20
-
-
77951283497
-
Assessment of confounding factors affecting the tumor markers SMRP, CA125, and CYFRA21-1 in serum
-
D.G. Weber, G. Johnen, D. Taeger, A. Weber, I.M. Gross, B. Pesch, T. Kraus, T. Brüning and M. Gube, Assessment of confounding factors affecting the tumor markers SMRP, CA125, and CYFRA21-1 in serum, Biomark Insights 5 (2010), 1-8.
-
(2010)
Biomark Insights
, vol.5
, pp. 1-8
-
-
Weber, D.G.1
Johnen, G.2
Taeger, D.3
Weber, A.4
Gross, I.M.5
Pesch, B.6
Kraus, T.7
Brüning, T.8
Gube, M.9
-
21
-
-
79955640387
-
Generation and characterization of a high-affinity monoclonal antibody for MUC1 measurement in breast cancer
-
S.S. Hamid and S.H. Cheah, Generation and characterization of a high-affinity monoclonal antibody for MUC1 measurement in breast cancer, Hybridoma (Larchmt) 30 (2011), 137-143.
-
(2011)
Hybridoma (Larchmt)
, vol.30
, pp. 137-143
-
-
Hamid, S.S.1
Cheah, S.H.2
-
22
-
-
33646468280
-
Clinical significance of MUC1 and c-Met RT-PCR detection of circulating tumor cells in patients with gastric carcinoma
-
Y.H. Uen, S.R. Lin, C.H. Wu, J.S. Hsieh, C.Y. Lu, F.J. Yu, T.J. Huang and J.Y.Wang, Clinical significance of MUC1 and c-Met RT-PCR detection of circulating tumor cells in patients with gastric carcinoma, Clinica Chimica Acta 367 (2006), 55-61.
-
(2006)
Clinica Chimica Acta
, vol.367
, pp. 55-61
-
-
Uen, Y.H.1
Lin, S.R.2
Wu, C.H.3
Hsieh, J.S.4
Lu, C.Y.5
Yu, F.J.6
Huang, T.J.7
Wang, J.Y.8
-
23
-
-
84655164944
-
Expression and prognostic relevance of MUC1 in stage IB non-small cell lung cancer
-
D. Situ, J. Wang, Y. Ma, Z. Zhu, Y. Hu, H. Long and T. Rong, Expression and prognostic relevance of MUC1 in stage IB non-small cell lung cancer, Medical Oncology 28 (2011), S596-S604.
-
(2011)
Medical Oncology
, vol.28
, pp. S596-S604
-
-
Situ, D.1
Wang, J.2
Ma, Y.3
Zhu, Z.4
Hu, Y.5
Long, H.6
Rong, T.7
-
24
-
-
47649084543
-
BLP-25 liposomal vaccine: A promising potential therapy in non-small-cell lung cancer
-
E. Powell and L.Q. Chow, BLP-25 liposomal vaccine: A promising potential therapy in non-small-cell lung cancer, Expert Review of Respiratory Medicine 2 (2008), 37-45.
-
(2008)
Expert Review of Respiratory Medicine
, vol.2
, pp. 37-45
-
-
Powell, E.1
Chow, L.Q.2
-
25
-
-
84877948266
-
MUC1 and bcl-2 expression in preinvasive lesions and adenosquamous carcinoma of the lung
-
F. Demirag, E. Cakir, H. Bayiz and U. Eren Yazici, MUC1 and bcl-2 expression in preinvasive lesions and adenosquamous carcinoma of the lung, Acta Chirurgica Belgica 113 (2013), 19-24.
-
(2013)
Acta Chirurgica Belgica
, vol.113
, pp. 19-24
-
-
Demirag, F.1
Cakir, E.2
Bayiz, H.3
Eren Yazici, U.4
-
26
-
-
70349900689
-
Clinical significance of a serum CA15-3 surge and the usefulness of CA15-3 kinetics in monitoring chemotherapy response in patients with metastatic breast cancer
-
H.S. Kim, Y.H. Park, M.J. Park, M.H. Chang, H.J. Jun, K.H. Kim, J.S. Ahn, W.K. Kang, K. Park and Y.H. Im, Clinical significance of a serum CA15-3 surge and the usefulness of CA15-3 kinetics in monitoring chemotherapy response in patients with metastatic breast cancer, Breast Cancer Research and Treatment 18 (2009), 89-97.
-
(2009)
Breast Cancer Research and Treatment
, vol.18
, pp. 89-97
-
-
Kim, H.S.1
Park, Y.H.2
Park, M.J.3
Chang, M.H.4
Jun, H.J.5
Kim, K.H.6
Ahn, J.S.7
Kang, W.K.8
Park, K.9
Im, Y.H.10
-
27
-
-
84871671473
-
Relationships among serum CA15-3 tumor marker, TNM staging, and estrogen and progesterone receptor expression in benign and malignant breast lesions
-
M. Atoum, N. Nimer, S. Abdeldayem and H. Nasr, Relationships among serum CA15-3 tumor marker, TNM staging, and estrogen and progesterone receptor expression in benign and malignant breast lesions, Asian Pacific Journal of Cancer Prevention 13 (2012), 857-860.
-
(2012)
Asian Pacific Journal of Cancer Prevention
, vol.13
, pp. 857-860
-
-
Atoum, M.1
Nimer, N.2
Abdeldayem, S.3
Nasr, H.4
-
28
-
-
0242267121
-
Tissue and serum MUC1 mucin detection in breast cancer patients
-
M.V. Croce, M.T. Isla-Larrain, S.O. Demichelis, A. Segal-Eiras, J.R. Gori and M.R. Price, Tissue and serum MUC1 mucin detection in breast cancer patients, Breast Cancer Research and Treatment 81 (2003), 195-207.
-
(2003)
Breast Cancer Research and Treatment
, vol.81
, pp. 195-207
-
-
Croce, M.V.1
Isla-Larrain, M.T.2
Demichelis, S.O.3
Segal-Eiras, A.4
Gori, J.R.5
Price, M.R.6
-
29
-
-
67650904948
-
Does the pre-operative value of serum CA15-3 correlate with survival in breast cancer?
-
S. Velaiutham, N.A. Taib, K.L. Ng, B.K. Yoong and C.H. Yip, Does the pre-operative value of serum CA15-3 correlate with survival in breast cancer? Asian Pacific Journal of Cancer Prevention 9 (2008), 445-448.
-
(2008)
Asian Pacific Journal of Cancer Prevention
, vol.9
, pp. 445-448
-
-
Velaiutham, S.1
Taib, N.A.2
Ng, K.L.3
Yoong, B.K.4
Yip, C.H.5
|